4 Articles
4 Articles
In addition to a very intense drowsiness during the day, many people with narcolepsy also suffer, among other symptoms, episodes of cataplegia, sudden loss and...
Narcolepsy cannot be treated causally – so far. A new active substance attacks the central disease mechanism for the first time. It seems to help.
Oveporexton reduces sleepiness in people with type 1 of the disease. While the US drug agency approved the product in August, patients hope that it will be the same in Europe.
Oveporexton, a new drug for narcolepsy, is showing promising results in phase 3 studies. The treatment could give new life to affected patients, but it will be some time before the drug becomes available in Sweden.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium






